Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sam van der Tuin"'
Autor:
Albert K. Groen, Inge Verkouter, Patrick C.N. Rensen, Yanan Wang, Sam van der Tuin, Ko Willems van Dijk, Zhuang Li, Jan B. van Klinken
Publikováno v:
Atherosclerosis, 263, E8-E9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00f89b237fb614dc104a5839049a329
http://hdl.handle.net/1887/94869
http://hdl.handle.net/1887/94869
Autor:
Elsbet J. Pieterman, Ko Willems van Dijk, Sam van der Tuin, Susan Kühnast, Jan B. van Klinken, Thomas F. Lüscher, Louis M. Havekes, Patrick C.N. Rensen, J. Wouter Jukema, Branko Simic, Ulf Landmesser, José W.A. van der Hoorn, Hans M.G. Princen
Publikováno v:
European Heart Journal, 1, 36, 39-48
European Heart Journal
European Heart Journal, 36(1), 39-48A
European Heart Journal
European Heart Journal, 36(1), 39-48A
The present study is the first intervention study in a well-established, translational mouse model for hyperlipidaemia and atherosclerosis showing that anacetrapib dose-dependently reduces atherosclerosis development and adds to the anti-atherogenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d54df54fbd657f7f662b0a589de691
https://doi.org/10.1093/eurheartj/ehu319
https://doi.org/10.1093/eurheartj/ehu319
Autor:
Yanan Wang, Ko Willems van Dijk, Biljana Atanasovska, Patrick C.N. Rensen, Siroon Bekkering, Nathanja Tjeerdema, Jimmy F.P. Berbée, Marten H. Hofker, Sander S. Rensen, Niels P. Riksen, Jan Greve, Menno Hoekstra, Ronit Shiri-Sverdlov, Jingyuan Fu, Onno C. Meijer, Louis M. Havekes, Wim A. Buurman, Sam van der Tuin, Andrea D. van Dam, Tim Hendrikx, Johannes W. A. Smit
Publikováno v:
Hepatology, 62, 1710-22
Hepatology, 62(6), 1710-1722
Hepatology, 62(6), 1710-1722. Wiley
Hepatology, 62, 6, pp. 1710-22
Hepatology, 62(6), 1710-1722
Hepatology, 62(6), 1710-1722. Wiley
Hepatology, 62, 6, pp. 1710-22
Contains fulltext : 152584.pdf (Publisher’s version ) (Closed access) The role of Kupffer cells (KCs) in the pathophysiology of the liver has been firmly established. Nevertheless, KCs have been underexplored as a target for diagnosis and treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e74b4f5c1e049fbd2ed44f82e54f98
http://hdl.handle.net/2066/152584
http://hdl.handle.net/2066/152584
Autor:
Marcel Wolfs, Louis M. Havekes, Marten H. Hofker, Patrick C.N. Rensen, Sam van der Tuin, Ronit Shiri-Sverdlov, Ko Willems van Dijk, Veerle Bieghs, Johannes W. A. Smit, Jingyuan Fu, Yanan Wang, Nathanja Tjeerdema, Sander S. Rensen
Publikováno v:
Nederlands Tijdschrift voor Diabetologie. 11:195-195
Cholesteryl ester transfer protein (CETP) transfers cholesteryl esters from HDL to LDL and high CETP activity results in an atherogenic lipid phenotype. Thus, inhibiting CETP is a target for dyslipidemia treatment. However, the true origin of CETP in